Focus on Women's Health

Focus on Women's Health

Focus on Women's Health

The women’s health market is predicted to be among the fastest growing investment areas within the healthcare and life sciences industry. Life sciences companies and healthcare providers, as well as the governmental bodies that regulate them, are abandoning a “one-size-fits-all” approach to treatment in favor of approaches more tailored to specific groups, including women. King & Spalding’s Women’s Health team has decades of experience advising companies in this space on issues that arise throughout the lifecycle of medical products – including intellectual property issues, corporate and M&A issues, FDA-related issues, issues related to product coverage and reimbursement, healthcare provider issues, and product liability issues.  Clients include drug and device manufacturers, health care providers, private equity firms, and others.  

Law360 Names King & Spalding’s Product Liability Practice a 2018 Practice Group of the Year for Sixth Straight Year


2013-2018

Law360 Names King & Spalding a Healthcare Practice Group of the Year for the Second Consecutive Year


2017-2018

Law360 Names King & Spalding a 2018 “Life Sciences Practice Group of the Year”


2016-2018

King & Spalding Wins Chambers USA’s 2018 Healthcare Award


2018

Daily Journal Names King & Spalding Defense Verdict as One of 2017’s Top Verdicts in California


2018

Icon close

Close

Recognition

Law360 Names King & Spalding’s Product Liability Practice a 2018 Practice Group of the Year for Sixth Straight Year


2013-2018

Law360 Names King & Spalding a Healthcare Practice Group of the Year for the Second Consecutive Year


2017-2018

Law360 Names King & Spalding a 2018 “Life Sciences Practice Group of the Year”


2016-2018

King & Spalding Wins Chambers USA’s 2018 Healthcare Award


2018

Daily Journal Names King & Spalding Defense Verdict as One of 2017’s Top Verdicts in California


2018